Felix Sigal, DPM
Foot & Ankle Surgery · Los Angeles, CANPI 1710974522
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,315 of the $3,646 with a category attached, or 63.5%. 22 manufacturers reported payments, led by Integra Lifesciences Corporation at 42.7% of the total. 2025 is the largest year on record at $1,134, 3.5 times the $326 reported in 2019.
Across 87 payments — averaging $41.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$2K
- Paratek Pharmaceuticals, Inc.$437
- Smith+Nephew$413
- ETS Wound Care LLC$280
- Polarityte, Inc.$189
- Novo Nordisk$129
- plus $642 from 16 others
Across 737 payments — averaging $3606.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vanda Pharmaceuticals Inc.$611K
- Vertex$413K
- Novo Nordisk AS$401K
- Integra Lifesciences Corporation$250K
- AbbVie$161K
- Smith+Nephew$137K
- plus $686K from 10 others
What the payments were for
- Consulting fees$2005%
- Food & beverage$2,31563%
- Education$1294%
- Other$1,00227%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 15 | $1,557 |
| Paratek Pharmaceuticals, Inc. | 21 | $437 |
| Smith+Nephew | 20 | $413 |
| ETS Wound Care LLC | 2 | $280 |
| Polarityte, Inc. | 2 | $189 |
| Novo Nordisk | 4 | $129 |
| Urgo Medical North America, LLC | 1 | $123 |
| KCI USA, Inc. | 4 | $99 |
| Organogenesis Inc. | 4 | $85 |
| Cardiovascular Systems Inc. | 1 | $77 |
| Polynovo North America LLC | 2 | $36 |
| Solventum Corporation | 1 | $34 |
| Acera Surgical, Inc. | 1 | $29 |
| Orthofix Medical, Inc. | 1 | $23 |
| Mimedx Group, Inc. | 1 | $22 |
| Aroa Biosurgery Incorporated | 1 | $20 |
| Osiris Therapeutics Inc. | 1 | $19 |
| Venclose Inc. | 1 | $18 |
| Melinta Therapeutics, LLC | 1 | $17 |
| Acell, Inc. | 1 | $13 |
| Angiodynamics, Inc. | 1 | $13 |
| Amniox Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,646 in reported general payments places this provider in the 65th percentile of 1,126 foot & ankle surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meropenem | 12 | $1,322 |
| Terbinafine Hcl | 12 | $187 |
| Ciclopirox | 13 | $169 |
| ClopidogrelClopidogrel Bisulfate | 13 | $20 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Los Angeles
- Eric TanLos Angeles$447K
- Timothy CharltonLos Angeles$125K
- Christopher KiddLos Angeles$60K
- Eric GizaSacramento$3.6M
- Thomas HarrisPasadena$3M
- Thomas ChangSanta Rosa$2M
- Michael CoughlinSan Francisco$1.6M
- Vladimir ZeetserEncino$677K
- Jason NowakRedding$526K
- Candice BradyCamarillo$462K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.